TMEM184A: A Potential Drug Target and Biomarker for Uncharacterized Protein MGC9712-Like

Target Name: TMEM184A

NCBI ID: G202915

TMEM184A

TMEM184A: A Potential Drug Target and Biomarker for Uncharacterized Protein MGC9712-Like

Abstract:

TMEM184A is a highly conserved protein that has been identified as a potential drug target and biomarker. It is part of the transmembrane protein family, which are involved in various physiological processes in the cell. TMEM184A has been shown to interact with various signaling molecules, including TGF-β1, HSP70, and NF-kappa-B. Additionally, it has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. The potential drug target and biomarker properties of TMEM184A make it an attractive candidate for further research and development.

Introduction:

Transmembrane proteins (TMs) are a diverse family of proteins that play a critical role in various cellular processes. TMs are involved in not only cellular signaling but also in the regulation of cellular structure and function. There are over 20 different families of TMs, including the transmembrane protein (TMP) family. TMEM184A is a member of the TMP family and has been identified as a potential drug target and biomarker.

TMEM184A is a 21-kDa protein that is expressed in various tissues and cells. It is involved in various cellular processes, including cell adhesion, migration, and invasion. TMEM184A is a transmembrane protein that is characterized by the presence of a single transmembrane domain and various intracellular loops. The transmembrane domain of TMEM184A is rich in various conserved amino acids, including alanine, aspartic acid, and glutamic acid, which are involved in the formation of helices and helices that are important for protein stability and function.

TMEM184A has been shown to interact with various signaling molecules, including TGF-β1, HSP70, and NF-kappa-B. TGF-β1 is a well-known signaling molecule that plays a critical role in cell growth, differentiation, and survival. HSP70 is a protein that is involved in the regulation of various cellular processes, including stress responses, DNA damage repair, and cell signaling. NF-kappa-B is a signaling molecule that is involved in inflammation, pain, and various cellular processes.

In addition to its potential role in signaling pathways, TMEM184A has also been shown to play a role in the regulation of cellular structure and function. TMEM184A has been shown to be involved in the regulation of cell adhesion, as well as the formation of tight junctions and tight junctions. Additionally, TMEM184A has been shown to be involved in the regulation of cell migration and invasion, as well as the regulation of cell survival.

Drug Targeting:

TMEM184A has been identified as a potential drug target due to its unique structure and various roles in cellular processes. One of the main drug targets for TMEM184A is the regulation of cell adhesion. TMEM184A has been shown to play a role in the regulation of cell-cell adhesion, as well as the regulation of cell-cell contacts. Additionally, TMEM184A has been shown to be involved in the regulation of tight junction formation, which is a critical aspect of cell-cell adhesion.

Another potential drug target for TMEM184A is the regulation of cell migration and invasion. TMEM184A has been shown to play a role in the regulation of cell migration, as well as the regulation of cell invasion. Additionally, TMEM184A has

Protein Name: Transmembrane Protein 184A

Functions: Acts as a heparin receptor in vascular cells (By similarity). May be involved in vesicle transport in exocrine cells and Sertoli cells (By similarity)

The "TMEM184A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM184A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets